Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Modified Jessner's solution is a chemical peel formulation used in dermatology and cosmetic procedures for skin resurfacing. It is a milder alternative to the original Jessner's solution, replacing resorcinol with citric acid to reduce potential side effects such as allergic reactions and endocrine disruption. The typical composition includes 17% lactic acid (an alpha hydroxy acid), 17% salicylic acid (a beta hydroxy acid), and 8% citric acid, all dissolved in ethanol[1][2][3][5][6]. This combination provides both superficial exfoliation and deeper penetration into the skin layers, making it effective for treating hyperpigmentation, acne scars, melasma, fine lines, uneven skin tone, and other epidermal lesions[5][7][9]. The mechanism of action involves keratolysis (exfoliation) by breaking down intercellular bonds in the stratum corneum through both AHAs and BHAs. Modified Jessner’s peels are self-neutralizing and typically do not require timing or neutralization steps during application[8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on modified jessner's solution.